Human medicines European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals), pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Influenza, Human,Immunization,Disease Outbreaks, Date of authorisation: 10/10/2009, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune), pandemic influenza vaccine (H5N1) (live attenuated, nasal), Influenza, Human, Date of authorisation: 20/05/2016, Revision: 3, Status: Authorised